バイオシミラーインスリンの世界市場レポート2020

• 英文タイトル：Global Biosimilar Insulin Sales Market Report 2020

• レポートコード：20QY06-02715 • 出版社/出版日：QYResearch / 2020年6月3日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ
Enterprise License	￥1,184,000 (USD8,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社の当調査資料では、バイオシミラーインスリンのグローバル市場について種類別（速効型インスリン、短時間作用型インスリン、中間型インスリン、長期持続型インスリン）、用途別（病院、クリニック、医療センター）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・バイオシミラーインスリン市場の概要 ・世界の主要地域別バイオシミラーインスリン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のバイオシミラーインスリン市場規模2015-2026：種類別（速効型インスリン、短時間作用型インスリン、中間型インスリン、長期持続型インスリン） ・世界のバイオシミラーインスリン市場規模2015-2026：用途別（病院、クリニック、医療センター） ・バイオシミラーインスリンの北米市場規模2015-2020 ・バイオシミラーインスリンのヨーロッパ市場規模2015-2020 ・バイオシミラーインスリンの中国市場規模2015-2020 ・バイオシミラーインスリンの日本市場規模2015-2020 ・バイオシミラーインスリンの東南アジア市場規模2015-2020 ・バイオシミラーインスリンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Pfizer、、Biogenomics、、Eli Lilly、、Gan&Lee Pharmaceuticals、、Geropharm、、Julphar Gulf Pharmaceutical Industries、、Paras Biopharmaceuticals、、Samsung Bioepis、、Sedico、、Wockhardt、、Teva Pharmaceuticals、） ・バイオシミラーインスリンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・バイオシミラーインスリンの市場動向・機会・課題 ・調査の結論

Market Analysis and Insights: Global Biosimilar Insulin Market

The global Biosimilar Insulin market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026.

Global Biosimilar Insulin Scope and Market Size

The global Biosimilar Insulin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar Insulin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Biosimilar Insulin market is segmented into

Rapid Acting Insulins

Short Acting Insulins

Intermediate Insulins

Long Lasting Insulins

Segment by Application, the Biosimilar Insulin market is segmented into

Hospital

Clinic

Medical Center

The Biosimilar Insulin market is analysed and market size information is provided by regions (countries). Segment by Application, the Biosimilar Insulin market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.

The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Biosimilar Insulin Market Share Analysis

Biosimilar Insulin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Biosimilar Insulin business, the date to enter into the Biosimilar Insulin market, Biosimilar Insulin product introduction, recent developments, etc.

The major vendors covered:

Pfizer

Biogenomics

Eli Lilly

Gan&Lee Pharmaceuticals

Geropharm

Julphar Gulf Pharmaceutical Industries

Paras Biopharmaceuticals

Samsung Bioepis

Sedico

Wockhardt

Teva Pharmaceuticals

レポート目次

---

Table of Contents

1 Biosimilar Insulin Market Overview

1.1 Biosimilar Insulin Product Scope

1.2 Biosimilar Insulin Segment by Type

1.2.1 Global Biosimilar Insulin Sales by Type (2020-2026)

1.2.2 Rapid Acting Insulins

1.2.3 Short Acting Insulins

1.2.4 Intermediate Insulins

1.2.5 Long Lasting Insulins

1.3 Biosimilar Insulin Segment by Application

1.3.1 Global Biosimilar Insulin Sales Comparison by Application (2020-2026)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Medical Center

1.4 Biosimilar Insulin Market Estimates and Forecasts (2015-2026)

1.4.1 Global Biosimilar Insulin Sales Growth Rate (2015-2026)

1.4.2 Global Biosimilar Insulin Revenue and Growth Rate (2015-2026)

1.4.3 Global Biosimilar Insulin Price Trends (2015-2026)

2 Biosimilar Insulin Estimate and Forecast by Region

2.1 Global Biosimilar Insulin Market Size by Region: 2015 VS 2020 VS 2026

2.2 Global Biosimilar Insulin Retrospective Market Scenario by Region (2015-2020)

2.2.1 Global Biosimilar Insulin Sales Market Share by Region (2015-2020)

2.2.2 Global Biosimilar Insulin Revenue Market Share by Region (2015-2020)

2.3 Global Biosimilar Insulin Market Estimates and Forecasts by Region (2021-2026)

2.3.1 Global Biosimilar Insulin Sales Estimates and Forecasts by Region (2021-2026)

2.3.2 Global Biosimilar Insulin Revenue Forecast by Region (2021-2026)

2.4 Geographic Market Analysis: Market Facts & Figures

2.4.1 United States Biosimilar Insulin Estimates and Projections (2015-2026)

2.4.2 Europe Biosimilar Insulin Estimates and Projections (2015-2026)

2.4.3 China Biosimilar Insulin Estimates and Projections (2015-2026)

2.4.4 Japan Biosimilar Insulin Estimates and Projections (2015-2026)

2.4.5 Southeast Asia Biosimilar Insulin Estimates and Projections (2015-2026)

2.4.6 India Biosimilar Insulin Estimates and Projections (2015-2026)

3 Global Biosimilar Insulin Competition Landscape by Players

3.1 Global Top Biosimilar Insulin Players by Sales (2015-2020)

3.2 Global Top Biosimilar Insulin Players by Revenue (2015-2020)

3.3 Global Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Insulin as of 2019)

3.4 Global Biosimilar Insulin Average Price by Company (2015-2020)

3.5 Manufacturers Biosimilar Insulin Manufacturing Sites, Area Served, Product Type

3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3.7 Primary Interviews with Key Biosimilar Insulin Players (Opinion Leaders)

4 Global Biosimilar Insulin Market Size by Type

4.1 Global Biosimilar Insulin Historic Market Review by Type (2015-2020)

4.1.1 Global Biosimilar Insulin Sales Market Share by Type (2015-2020)

4.1.2 Global Biosimilar Insulin Revenue Market Share by Type (2015-2020)

4.1.3 Global Biosimilar Insulin Price by Type (2014-2020)

4.2 Global Biosimilar Insulin Market Estimates and Forecasts by Type (2021-2026)

4.2.1 Global Biosimilar Insulin Sales Forecast by Type (2021-2026)

4.2.2 Global Biosimilar Insulin Revenue Forecast by Type (2021-2026)

4.2.3 Global Biosimilar Insulin Price Forecast by Type (2021-2026)

5 Global Biosimilar Insulin Market Size by Application

5.1 Global Biosimilar Insulin Historic Market Review by Application (2015-2020)

5.1.1 Global Biosimilar Insulin Sales Market Share by Application (2015-2020)

5.1.2 Global Biosimilar Insulin Revenue Market Share by Application (2015-2020)

5.1.3 Global Biosimilar Insulin Price by Application (2015-2020)

5.2 Global Biosimilar Insulin Market Estimates and Forecasts by Application (2021-2026)

5.2.1 Global Biosimilar Insulin Sales Forecast by Application (2021-2026)

5.2.2 Global Biosimilar Insulin Revenue Forecast by Application (2021-2026)

5.2.3 Global Biosimilar Insulin Price Forecast by Application (2021-2026)

3 North America Biosimilar Insulin Market Facts & Figures

3.2 North America Biosimilar Insulin Sales Market Share by Company (2015-2020)

3.3 North America Biosimilar Insulin Sales Market Share by Type (2015-2020)

3.4 North America Biosimilar Insulin Sales Market Share by Application (2015-2020)

4 Europe Biosimilar Insulin Market Facts & Figures

4.2 Europe Biosimilar Insulin Sales Market Share by Company (2015-2020)

4.3 Europe Biosimilar Insulin Sales Market Share by Type (2015-2020)

4.4 Europe Biosimilar Insulin Sales Market Share by Application (2015-2020)

5 China Biosimilar Insulin Market Facts & Figures

5.2 China Biosimilar Insulin Sales Market Share by Company (2015-2020)

5.3 China Biosimilar Insulin Sales Market Share by Type (2015-2020)

5.4 China Biosimilar Insulin Sales Market Share by Application (2015-2020)

6 Japan Biosimilar Insulin Market Facts & Figures

6.2 Japan Biosimilar Insulin Sales Market Share by Company (2015-2020)

6.3 Japan Biosimilar Insulin Sales Market Share by Type (2015-2020)

6.4 Japan Biosimilar Insulin Sales Market Share by Application (2015-2020)

7 Southeast Asia Biosimilar Insulin Market Facts & Figures

7.2 Southeast Asia Biosimilar Insulin Sales Market Share by Company (2015-2020)

7.3 Southeast Asia Biosimilar Insulin Sales Market Share by Type (2015-2020)

7.4 Southeast Asia Biosimilar Insulin Sales Market Share by Application (2015-2020)

8 India Biosimilar Insulin Market Facts & Figures

8.2 India Biosimilar Insulin Sales Market Share by Company (2015-2020)

8.3 India Biosimilar Insulin Sales Market Share by Type (2015-2020)

8.4 India Biosimilar Insulin Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Biosimilar Insulin Business

12.1 Pfizer

12.1.1 Pfizer Biosimilar Insulin Corporation Information

12.1.2 Pfizer Biosimilar Insulin Business Overview and Total Revenue

12.1.3 Pfizer Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.1.4 Pfizer Biosimilar Insulin Products Offered

12.1.5 Pfizer Recent Development

12.2 Biogenomics

12.2.1 Biogenomics Biosimilar Insulin Corporation Information

12.2.2 Biogenomics Biosimilar Insulin Business Overview and Total Revenue

12.2.3 Biogenomics Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.2.4 Biogenomics Biosimilar Insulin Products Offered

12.2.5 Biogenomics Recent Development

12.3 Eli Lilly

12.3.1 Eli Lilly Biosimilar Insulin Corporation Information

12.3.2 Eli Lilly Biosimilar Insulin Business Overview and Total Revenue

12.3.3 Eli Lilly Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.3.4 Eli Lilly Biosimilar Insulin Products Offered

12.3.5 Eli Lilly Recent Development

12.4 Gan&Lee Pharmaceuticals

12.4.1 Gan&Lee Pharmaceuticals Biosimilar Insulin Corporation Information

12.4.2 Gan&Lee Pharmaceuticals Biosimilar Insulin Business Overview and Total Revenue

12.4.3 Gan&Lee Pharmaceuticals Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.4.4 Gan&Lee Pharmaceuticals Biosimilar Insulin Products Offered

12.4.5 Gan&Lee Pharmaceuticals Recent Development

12.5 Geropharm

12.5.1 Geropharm Biosimilar Insulin Corporation Information

12.5.2 Geropharm Biosimilar Insulin Business Overview and Total Revenue

12.5.3 Geropharm Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.5.4 Geropharm Biosimilar Insulin Products Offered

12.5.5 Geropharm Recent Development

12.6 Julphar Gulf Pharmaceutical Industries

12.6.1 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Corporation Information

12.6.2 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Business Overview and Total Revenue

12.6.3 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.6.4 Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Products Offered

12.6.5 Julphar Gulf Pharmaceutical Industries Recent Development

12.7 Paras Biopharmaceuticals

12.7.1 Paras Biopharmaceuticals Biosimilar Insulin Corporation Information

12.7.2 Paras Biopharmaceuticals Biosimilar Insulin Business Overview and Total Revenue

12.7.3 Paras Biopharmaceuticals Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.7.4 Paras Biopharmaceuticals Biosimilar Insulin Products Offered

12.7.5 Paras Biopharmaceuticals Recent Development

12.8 Samsung Bioepis

12.8.1 Samsung Bioepis Biosimilar Insulin Corporation Information

12.8.2 Samsung Bioepis Biosimilar Insulin Business Overview and Total Revenue

12.8.3 Samsung Bioepis Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.8.4 Samsung Bioepis Biosimilar Insulin Products Offered

12.8.5 Samsung Bioepis Recent Development

12.9 Sedico

12.9.1 Sedico Biosimilar Insulin Corporation Information

12.9.2 Sedico Biosimilar Insulin Business Overview and Total Revenue

12.9.3 Sedico Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.9.4 Sedico Biosimilar Insulin Products Offered

12.9.5 Sedico Recent Development

12.10 Wockhardt

12.10.1 Wockhardt Biosimilar Insulin Corporation Information

12.10.2 Wockhardt Biosimilar Insulin Business Overview and Total Revenue

12.10.3 Wockhardt Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.10.4 Wockhardt Biosimilar Insulin Products Offered

12.10.5 Wockhardt Recent Development

12.11 Teva Pharmaceuticals

12.11.1 Teva Pharmaceuticals Biosimilar Insulin Corporation Information

12.11.2 Teva Pharmaceuticals Biosimilar Insulin Business Overview and Total Revenue

12.11.3 Teva Pharmaceuticals Biosimilar Insulin Sales, Revenue and Gross Margin (2015-2020)

12.11.4 Teva Pharmaceuticals Biosimilar Insulin Products Offered

12.11.5 Teva Pharmaceuticals Recent Development

13 Biosimilar Insulin Manufacturing Cost Analysis

13.1 Biosimilar Insulin Key Raw Materials Analysis

13.1.1 Key Raw Materials

13.1.2 Key Raw Materials Price Trend

13.1.3 Key Suppliers of Raw Materials

13.2 Proportion of Manufacturing Cost Structure

13.3 Manufacturing Process Analysis of Biosimilar Insulin

13.4 Biosimilar Insulin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

14.1 Marketing Channel

14.2 Biosimilar Insulin Distributors List

14.3 Biosimilar Insulin Customers

15 Market Dynamics

15.1 Market Trends

15.2 Opportunities and Drivers

15.3 Challenges

15.4 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix

17.1 Research Methodology

17.1.1 Methodology/Research Approach

17.1.2 Data Source

17.2 Author List

17.3 Disclaimer

List of Tables



Table 1. Global Biosimilar Insulin Sales (K Pcs) Growth Rate by Type (2020-2026)

Table 2. Global Biosimilar Insulin Sales (K Pcs) Comparison by Application (2020-2026)

Table 3. Global Market Biosimilar Insulin Market Size (US$ Million) by Region:2015 VS 2020 &2026

Table 4. Global Biosimilar Insulin Sales (K Pcs) by Region (2015-2020)

Table 5. Global Biosimilar Insulin Sales Market Share by Region (2015-2020)

Table 6. Global Biosimilar Insulin Revenue (US$ Million) Market Share by Region (2015-2020))

Table 7. Global Biosimilar Insulin Revenue Share by Region (2015-2020)

Table 8. Global Biosimilar Insulin Sales (K Pcs) Forecast by Region (2021-2026)

Table 9. Global Biosimilar Insulin Sales Market Share Forecast by Region (2021-2026)

Table 10. Global Biosimilar Insulin Revenue (US$ Million) Forecast by Region (2021-2026)

Table 11. Global Biosimilar Insulin Revenue Share Forecast by Region (2021-2026)

Table 12. Global Biosimilar Insulin (K Pcs) of Key Companies (2015-2020)

Table 13. Global Biosimilar Insulin Sales Share by Company (2015-2020)

Table 14. Global Biosimilar Insulin Revenue (US$ Million) by Company (2015-2020)

Table 15. Global Biosimilar Insulin Revenue Share by Company (2015-2020)

Table 16. Global Biosimilar Insulin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Insulin as of 2019)

Table 17. Global Biosimilar Insulin Average Price (USD/Pcs) of Key Company (2015-2020)

Table 18. Manufacturers Biosimilar Insulin Manufacturing Sites and Area Served

Table 19. Manufacturers Biosimilar Insulin Product Type

Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 21. Main Points Interviewed from Key Biosimilar Insulin Players

Table 22. Global Biosimilar Insulin Sales (K Pcs) by Type (2015-2020)

Table 23. Global Biosimilar Insulin Sales Share by Type (2015-2020)

Table 24. Global Biosimilar Insulin Revenue (US$ Million) Market Share by Type (2015-2020)

Table 25. Global Biosimilar Insulin Price (K Pcs) by Type (2015-2020)

Table 26. Global Biosimilar Insulin Sales Share by Type (2021-2026)

Table 27. Global Biosimilar Insulin Revenue (US$ Million) Market Share by Type (2021-2026)

Table 28. Global Biosimilar Insulin Revenue Share by Type (2021-2026)

Table 29. Global Biosimilar Insulin Price (K Pcs) by Type (2021-2026)

Table 30. Global Biosimilar Insulin Sales (K Pcs) by Application (2015-2020)

Table 31. Global Biosimilar Insulin Sales Share by Application (2015-2020)

Table 32. Global Biosimilar Insulin Revenue (US$ Million) Market Share by Application (2015-2020)

Table 33. Global Biosimilar Insulin Price (K Pcs) by Application (2015-2020)

Table 34. Global Biosimilar Insulin Sales (K Pcs) by Application (2021-2026)

Table 35. Global Biosimilar Insulin Sales Share by Application (2021-2026)

Table 36. Global Biosimilar Insulin Revenue (US$ Million) Market Share by Application (2021-2026)

Table 37. Global Biosimilar Insulin Revenue Share by Application (2021-2026)

Table 38. Global Biosimilar Insulin Price (K Pcs) by Application (2021-2026)

Table 39. United States Biosimilar Insulin Sales (K Pcs) by Company (2015-2020)

Table 40. United States Biosimilar Insulin Sales Market Share by Company (2015-2020)

Table 41. United States Biosimilar Insulin Sales (K Pcs) by Type (2015-2020)

Table 42. United States Biosimilar Insulin Sales Market Share by Type (2015-2020)

Table 43. United States Biosimilar Insulin Sales (K Pcs) by Application (2015-2020)

Table 44. United States Biosimilar Insulin Sales Market Share by Application (2015-2020)

Table 45. Europe Biosimilar Insulin Sales (K Pcs) by Company (2015-2020)

Table 46. Europe Biosimilar Insulin Sales Market Share by Company (2015-2020)

Table 47. Europe Biosimilar Insulin Sales (K Pcs) by Type (2015-2020)

Table 48. Europe Biosimilar Insulin Sales Market Share by Type (2015-2020)

Table 49. Europe Biosimilar Insulin Sales (K Pcs) by Application (2015-2020)

Table 50. Europe Biosimilar Insulin Sales Market Share by Type (2015-2020)

Table 51. China Biosimilar Insulin Sales (K Pcs) by Company (2015-2020)

Table 52. China Biosimilar Insulin Sales Market Share by Company (2015-2020)

Table 53. China Biosimilar Insulin Sales (K Pcs) by Type (2015-2020)

Table 54. China Biosimilar Insulin Sales Market Share by Type (2015-2020)

Table 55. China Biosimilar Insulin Sales (K Pcs) by Application (2015-2020)

Table 56. China Biosimilar Insulin Sales Market Share by Application (2015-2020)

Table 57. Japan Biosimilar Insulin Sales (K Pcs) by Company (2015-2020)

Table 58. Japan Biosimilar Insulin Sales Market Share by Company (2015-2020)

Table 59. Japan Biosimilar Insulin Sales (K Pcs) by Type (2015-2020)

Table 60. Japan Biosimilar Insulin Sales Market Share by Type (2015-2020)

Table 61. Japan Biosimilar Insulin Sales (K Pcs) by Application (2015-2020)

Table 62. Japan Biosimilar Insulin Sales Market Share by Application (2015-2020)

Table 63. Southeast Asia Biosimilar Insulin Sales (K Pcs) by Company (2015-2020)

Table 64. Southeast Asia Biosimilar Insulin Sales Market Share by Company (2015-2020)

Table 65. Southeast Asia Biosimilar Insulin Sales (K Pcs) by Type (2015-2020)

Table 66. Southeast Asia Biosimilar Insulin Sales Market Share by Type (2015-2020)

Table 67. Southeast Asia Biosimilar Insulin Sales (K Pcs) by Type (2015-2020)

Table 68. Southeast Asia Biosimilar Insulin Sales Market Share by Application (2015-2020)

Table 69. India Biosimilar Insulin Sales (K Pcs) by Company (2015-2020)

Table 70. India Biosimilar Insulin Sales Market Share by Company (2015-2020)

Table 71. India Biosimilar Insulin Sales (K Pcs) by Type (2015-2020)

Table 72. India Biosimilar Insulin Sales Market Share by Type (2015-2020)

Table 73. India Biosimilar Insulin Sales (K Pcs) by Application (2015-2020)

Table 74. India Biosimilar Insulin Sales Market Share by Application (2015-2020)

Table 75. Pfizer Corporation Information

Table 76. Pfizer Description and Business Overview

Table 77. Pfizer Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 78. Pfizer Biosimilar Insulin Product

Table 79. Pfizer Recent Development

Table 80. Biogenomics Corporation Information

Table 81. Biogenomics Description and Business Overview

Table 82. Biogenomics Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 83. Biogenomics Biosimilar Insulin Product

Table 84. Biogenomics Recent Development

Table 85. Eli Lilly Corporation Information

Table 86. Eli Lilly Description and Business Overview

Table 87. Eli Lilly Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 88. Eli Lilly Biosimilar Insulin Product

Table 89. Eli Lilly Recent Development

Table 90. Gan&Lee Pharmaceuticals Corporation Information

Table 91. Gan&Lee Pharmaceuticals Description and Business Overview

Table 92. Gan&Lee Pharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 93. Gan&Lee Pharmaceuticals Biosimilar Insulin Product

Table 94. Gan&Lee Pharmaceuticals Recent Development

Table 95. Geropharm Corporation Information

Table 96. Geropharm Description and Business Overview

Table 97. Geropharm Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 98. Geropharm Biosimilar Insulin Product

Table 99. Geropharm Recent Development

Table 100. Julphar Gulf Pharmaceutical Industries Corporation Information

Table 101. Julphar Gulf Pharmaceutical Industries Description and Business Overview

Table 102. Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 103. Julphar Gulf Pharmaceutical Industries Biosimilar Insulin Product

Table 104. Julphar Gulf Pharmaceutical Industries Recent Development

Table 105. Paras Biopharmaceuticals Corporation Information

Table 106. Paras Biopharmaceuticals Description and Business Overview

Table 107. Paras Biopharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 108. Paras Biopharmaceuticals Biosimilar Insulin Product

Table 109. Paras Biopharmaceuticals Recent Development

Table 110. Samsung Bioepis Corporation Information

Table 111. Samsung Bioepis Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 112. Samsung Bioepis Description and Business Overview

Table 113. Samsung Bioepis Biosimilar Insulin Product

Table 114. Samsung Bioepis Recent Development

Table 115. Sedico Corporation Information

Table 116. Sedico Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 117. Sedico Description and Business Overview

Table 118. Sedico Biosimilar Insulin Product

Table 119. Sedico Recent Development

Table 120. Wockhardt Corporation Information

Table 121. Wockhardt Description and Business Overview

Table 122. Wockhardt Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 123. Wockhardt Biosimilar Insulin Product

Table 124. Wockhardt Recent Development

Table 125. Teva Pharmaceuticals Corporation Information

Table 126. Teva Pharmaceuticals Description and Business Overview

Table 127. Teva Pharmaceuticals Biosimilar Insulin Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2015-2020)

Table 128. Teva Pharmaceuticals Biosimilar Insulin Product

Table 129. Teva Pharmaceuticals Recent Development

Table 130. Production Base and Market Concentration Rate of Raw Material

Table 131. Key Suppliers of Raw Materials

Table 132. Biosimilar Insulin Distributors List

Table 133. Biosimilar Insulin Customers List

Table 134. Market Key Trends

Table 135. Key Opportunities and Drivers: Impact Analysis (2020-2026)

Table 136. Key Challenges

Table 137. Research Programs/Design for This Report

Table 138. Key Data Information from Secondary Sources

Table 139. Key Data Information from Primary Sources

List of Figures

Figure 1. Biosimilar Insulin Product Picture

Figure 2. Global Biosimilar Insulin Sales Market Share by Type in 2020 & 2026

Figure 3. Type I Product Picture

Figure 4. Type II Product Picture

Figure 5. Global Biosimilar Insulin Market Share by Application in 2020 & 2026

Figure 6. Hospital Examples

Figure 7. Clinic Examples

Figure 8. Medical Center Examples

Figure 9. Global Biosimilar Insulin Sales (K Pcs) Growth Rate (2015-2026)

Figure 10. Global Biosimilar Insulin Revenue (US$ Million) Growth Rate (2015-2026)

Figure 11. Global Biosimilar Insulin Price Trends Growth Rate (2015-2026) (USD/Pcs)

Figure 12. Global Biosimilar Insulin Revenue Market Share by Region: 2015 VS 2020

Figure 13. Global Biosimilar Insulin Revenue Market Share by Region: 2021 VS 2026

Figure 14. United States Biosimilar Insulin Revenue (Million USD) Growth Rate (2015-2026)

Figure 15. United States Biosimilar Insulin Sales (K Pcs) Growth Rate (2015-2026)

Figure 16. Europe Biosimilar Insulin Revenue (Million USD) Growth Rate (2015-2026)

Figure 17. Europe Biosimilar Insulin Sales (Million USD) Growth Rate (2015-2026)

Figure 18. China Biosimilar Insulin Revenue (Million USD) Growth Rate (2015-2026)

Figure 19. China Biosimilar Insulin Sales (Million USD) and Growth Rate (2015-2026)

Figure 20. Japan Biosimilar Insulin Revenue (Million USD) Growth Rate (2015-2026)

Figure 21. Japan Biosimilar Insulin Sales (Million USD) Growth Rate (2015-2026)

Figure 22. Southeast Asia Biosimilar Insulin Revenue (Million USD) Growth Rate (2015-2026)

Figure 23. Southeast Asia Biosimilar Insulin Sales (Million USD) Growth Rate (2015-2026)

Figure 24. India Biosimilar Insulin Revenue (Million USD) Growth Rate (2015-2026)

Figure 25. India Biosimilar Insulin Sales (Million USD) Growth Rate (2015-2026)

Figure 26. Global 5 Largest Biosimilar Insulin Players Market Share by Revenue in Biosimilar Insulin 2015 & 2019

Figure 27. Biosimilar Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 28. Global Biosimilar Insulin Revenue Share by Type (2015-2020)

Figure 29. Global Biosimilar Insulin Revenue Growth Rate by Type in 2015 & 2019

Figure 30. Global Biosimilar Insulin Revenue Share by Application (2015-2020)

Figure 31. Global Biosimilar Insulin Revenue Growth Rate by Application in 2015 & 2019

Figure 32. United States Biosimilar Insulin Sales Market Share by Type in 2019

Figure 33. United States Biosimilar Insulin Sales Market Share by Type in 2019

Figure 34. Europe Biosimilar Insulin Sales Market Share by Company in 2019

Figure 35. Europe Biosimilar Insulin Sales Market Share by Type in 2019

Figure 36. Europe Biosimilar Insulin Sales Market Share by Application in 2019

Figure 37. China Biosimilar Insulin Sales Market Share by Company in 2019

Figure 38. China Biosimilar Insulin Sales Market Share by Type in 2019

Figure 39. China Biosimilar Insulin Sales Market Share by Application in 2019

Figure 40. Japan Biosimilar Insulin Sales Market Share by Company in 2019

Figure 41. Japan Biosimilar Insulin Sales Market Share by Type in 2019

Figure 42. Japan Biosimilar Insulin Sales Market Share by Application in 2019

Figure 43. Southeast Asia Biosimilar Insulin Sales Market Share by Company in 2019

Figure 44. Southeast Asia Biosimilar Insulin Sales Market Share by Type in 2019

Figure 45. Southeast Asia Biosimilar Insulin Sales Market Share by Application in 2019

Figure 46. India Biosimilar Insulin Sales Market Share by Company in 2019

Figure 47. India Biosimilar Insulin Sales Market Share by Type in 2019

Figure 48. India Biosimilar Insulin Sales Market Share by Application in 2019

Figure 49. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018

Figure 50. Biogenomics Total Revenue (US$ Million): 2019 Compared with 2018

Figure 51. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018

Figure 52. Gan&Lee Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 53. Geropharm Total Revenue (US$ Million): 2019 Compared with 2018

Figure 54. Julphar Gulf Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018

Figure 55. Paras Biopharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 56. Samsung Bioepis Total Revenue (US$ Million): 2019 Compared with 2018

Figure 57. Sedico Total Revenue (US$ Million): 2019 Compared with 2018

Figure 58. Wockhardt Total Revenue (US$ Million): 2019 Compared with 2018

Figure 59. Teva Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018

Figure 60. Key Raw Materials Price Trend

Figure 61. Manufacturing Cost Structure of Biosimilar Insulin

Figure 62. Manufacturing Process Analysis of Biosimilar Insulin

Figure 63. Biosimilar Insulin Industrial Chain Analysis

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

Figure 66. Porter's Five Forces Analysis

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

---